Skip to main content

MoneyWorks4Me

Lincoln Pharmaceuticals informs about board meeting

22 Oct 2026 Evaluate
Lincoln Pharmaceuticals has informed that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 to consider and approve Standalone and Consolidated Unaudited Financial Results of the Company for the Quarter and Half year ended 30.09.2026.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1903.00
Dr. Reddys Labs. 1398.00
Cipla 1416.00
Lupin 1999.00
Zydus Lifesciences 1200.00
View more..